Hot Features
Premium
Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Período:
Tipo de Línea:
| Volume | 0 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | Mínimo Máximo |
||||||
| Minimo del Dia | |||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Kiromic BioPharma Inc | KRBP | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.60 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.60 | 0.60 |
| Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
|---|---|---|---|
| 0 | 0 | - | 0.51 - 4.0799 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| - | 0 | US$ 0.60 | USD |
Información Financiera Kiromic BioPharma Inc KRBP
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 755.08k | 1.26M | - | 0 | -20.95M | -16.65 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Kiromic BioPharma Inc KRBP
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 29/5/2024 | 07:00 | Business Wire | Kiromic BioPharma Reports Favorable Results at Six Weeks.. |
| 22/5/2024 | 16:03 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 21/5/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/5/2024 | 16:00 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
| 20/5/2024 | 07:00 | Business Wire | Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical.. |
| 17/5/2024 | 15:43 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 24/4/2024 | 07:08 | Business Wire | Kiromic BioPharma Reports Consistent Favorable Safety,.. |
| 19/4/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/4/2024 | 15:30 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
| 05/4/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02/4/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02/4/2024 | 07:18 | Business Wire | Kiromic BioPharma Reports Favorable Safety, Tolerability,.. |
Histórico de Datos KRBP
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 3.51 | 4.0799 | 0.51 | 2.73 | 80,129 | -2.91 | -82.91% |
| 3 Years | 243.00 | 330.00 | 0.51 | 21.18 | 629,133 | -242.40 | -99.75% |
| 5 Years | 336.00 | 555.00 | 0.51 | 26.39 | 505,103 | -335.40 | -99.82% |
